Pioneering Prenatal Care: The Double Marker Test by DELFIA Xpress

The journey to parenthood is a time of wonder and anticipation. Ensuring the well-being of both the expectant mother and her unborn child is paramount. Enter the Double Marker test, a advance tool, and the DELFIA Xpress machine by Sterling Accuris, which together provide a revolutionary approach to prenatal screening. Let’s talk about what is double marker test and its significance and benefits of DELFIA.

What is the Double Marker Test?

The Double Marker test is a first-trimester prenatal screening method that measures Beta-hCG and PAPP-A levels in a pregnant woman's blood. This test plays a vital role in identifying the risk of chromosomal abnormalities in the developing fetus, offering early insights that can guide further medical decisions.

Significance of the Double Marker Test:

The Double Marker test holds immense significance for several reasons:

• Early Detection: By providing results in the first trimester, it enables early identification of potential chromosomal abnormalities, affording parents more time for informed decisions.

• Precision: The test's high accuracy in assessing the risk of chromosomal abnormalities is crucial, providing essential information for genetic counseling and further diagnostic tests.

• Reduced Invasive Procedures: The test helps minimize the need for invasive procedures like amniocentesis or chorionic villus sampling (CVS) by identifying low-risk pregnancies, thereby reducing potential risks.

Benefits of DELFIA Xpress:

Sterling Accuris' DELFIA Xpress offers a host of advantages that make it an indispensable tool in prenatal care:

• Cutting-Edge Technology: Staying at the forefront of medical technology, Sterling Accuris has introduced the DELFIA Xpress, which incorporates the latest advancements in diagnostics, ensuring top-notch accuracy and efficiency.

• FMF Certification: Certified by the Fetal Medicine Federation, this instrument is a testament to its reliability and trustworthiness.

• Compact Design: Its benchtop design saves valuable laboratory space, making it ideal for facilities with limited space.

• Efficiency: Users can customize databases for area-specific risk criteria, enhancing the efficiency of prenatal screening for Trisomy 21 (Down syndrome), Trisomy 18 (Edwards syndrome), and Trisomy 13 (Patau syndrome). This tailoring of risk factors assists both patients and doctors in more effectively identifying the highest risks.

• User-Friendly: The user-friendly interface ensures that healthcare professionals can perform tests with ease.

• OSCAR Integration: Seamless integration with the OSCAR system simplifies risk assessment, creating a one-stop clinic for assessing risk.

• Cost effective: it is a screening method and sensitivity is highly accurate.

Software:

It is a complete solution for handling the laboratory workflow from receipt of sample to reporting of results. LifeCycle™ software is designed to integrate seamlessly with PerkinElmer instruments and kits.

Conclusion:

Sterling Accuris, through the introduction of the DELFIA Xpress, has revolutionized prenatal screening with advanced technology. The Double Marker test, coupled with this state-of-the-art machine, empowers healthcare professionals to offer the best possible care to expectant parents. By staying at the forefront of medical technology, Sterling Accuris ensures that the journey to parenthood is supported by the latest innovations in healthcare.

In the ever-evolving landscape of prenatal care, Sterling Accuris has taken a pioneering step with the DELFIA Xpress, offering an innovative way to conduct the Double Marker test, backed by outstanding software and user-friendly design.

Innovation in Prenatal Care: Sterling Accuris Leads the Way.